Skip to main content
Sign in
Search form
Search this site
Top Menu
Newsletters
Español
Español
About the Study
Virtual TownHall
FAQ
For Providers
For Participants
Find your study site
California
UCLA CARE Center and Clinic
UCSF Mt. Zion Medical Center
Colorado
Denver Public Health
University of Colorado Denver
DC
Dupont Circle Physicians Group
Washington DC - Capital Digestive Care
Florida
University of Miami Health System
Georgia
Emory University - Grady Hospital
Illinois
Anal Dysplasia Clinic Midwest
Louisiana
Louisiana State University
Massachusetts
Boston Medical Center
New Jersey
NJMS Clinical Research Unit
New York
Cornell Clinical Trials Unit
Laser Surgery Care
Montefiore Medical Center
North Carolina
Wake Forest Baptist Medical Center
Puerto Rico
University of Puerto Rico
Washington
Harborview Medical Center
Virginia Mason Medical Center
Don't see your state?
Find out why
About the Study
A reality check (and resources!) on all things anal cancer
Featured & Fact 1
National Team
The CAB
Virtual TownHall
FAQ
Anal Cancer Basics
Anal Cancer Risk Compared
How is HSIL Treated?
Que es IRC?
What is HPV?
For Providers
Why Anchor?
What to Tell Patients
Evidence & Data
Accountability
For Participants
Contact Us
Newsletter
Insurance Resources
Search form
Search this site
Newsletters
The ANCHOR Study
Community Advisory Board
Meet the National Team
Anal Cancer Risk Compared
Study News
Frequently Asked Questions"
What is HPV?
Anal Cancer Basics
How is HSIL Treated?
How Do I Sign Up?
What Risks Are Involved?
What is IRC?
Atlanta - Emory
Boston Medical Center
Chicago - Midwest
Denver - Public Health
Denver - U. Colorado Denver
DC - Capital Digestive Care
DC - Dupont Circle
LA - UCLA Care Center
LA - UCLA School of Nursing
Miami
NOLA - Crescent Care
NOLA - LSU
NY - Cornell
NY - Laser Surgery Care
NY - Montefiore
Puerto Rico
San Francisco
Seattle - Harborview
Seattle - Polyclinic
Seattle - Virginia Mason
Winston-Salem
For Our Participants
Need a Reminder?
Let's Talk
Newsletter
For Providers
Why Anchor?
What to Tell Patients
Evidence & Data
Accountability
Half of HIV+ Men Have Anal Precancer
50% of HIV+ men have precancerous anal cells and almost all are symptom-free.
